361 results
EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stable CAD:
- Effects of visualization of PCI results on symptoms in chronic coronary syndrome
- Effect of Atorvastatin Therapy on Serial Changes of Coronary Flow And Plaque
- Initial results of a feasibility study of endovascular baroreflex amplification in heart failure patients
- Impact...
EuroPCR 2021 Hotlines / Late-Breaking Trials in CT-based FFR: DISCOVER FLOW & P3
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in CT-based FFR:
- Ten-year outcomes of coronary lesions assessed by CT angiography derived FFR
- Accuracy of the FFRCT Planner in Complex Coronary Artery Disease
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial
27 May 2021
ISCHEMIA-CKD is the only contemporary randomized trial that prospectively evaluated an upfront strategy of coronary angiography and revascularization plus optimal medical therapy (OMT) compared with OMT alone in patients listed for renal transplant.
Reviewer
Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...
A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study
20 May 2021 – From EuroPCR 2021
Watch this LBT session, which was originally presented during EuroPCR 2021, to find out more about the CASTLE study, whose aim is to access the results of two types of DES implanted with image guidance in all-comers.
EuroIntervention - Most discussed papers of the year
19 May 2021 – From EuroPCR 2021
Watch this session if you want to know the top 3 most discussed papers of the year which concern management of myocardial revascularisation failure, the impact of COVID-19 pandemic on interventional cardiology practice and Ischaemia witch non-obstructive coronary arteries.
This session was originally presented during EuroPCR 2021.
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21
Author
Is angio-based FFR ready to replace invasive FFR?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Joost Daemen and Ziad Ali in order to know more about physiological assessment in the cathlab and angio-based vFFR, the results of the multicentre vFFR clinical trial, and the future of angio-based FFR in the cathlab.
EuroPCR 2021 - Innovations in stents & scaffolds
18 May 2021 – From EuroPCR 2021
This session will enable you to find out more about arterial balloon with variable pressures, SPAS (stent positioning assistance systems), thrombectomy with a novel stent retriever in patients with large thrombus burden, and bionanosensored stents.
EuroPCR 2021 - Innovations in stable CAD
18 May 2021 – From EuroPCR 2021
In this session, consider the accuracy of OFR in assessing stenting result and residual disease, appraise a novel hybrid IVUS-OCT catheter system, and question whether NOCAD/INOCA patients could be diagnosed with a new physiological wire by obtaining pressure-derived CFR.
